TCL Archive GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer. November 2, 2007
TCL Archive In Brief: Sullivan Will Be Secretary Most Knowledgeable About Cancer Program; Ihde Names ‘JNCI’ Editor January 6, 1989
TCL Archive NIH to Review Intramural Program: NCI’s Intramural Spending is 17 Percent, Higher than 11.1 Percent NIH-Wide Level March 7, 2014
TCL Archive Also Cancer policy board urges NCI to convene panel on long-term care for childhood cancer survivors. October 10, 2003